- Home
- CELC vs IAC Comparison
CELC vs IAC Comparison
Compare CELC & IAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CELC | IAC |
|---|---|---|
| Founded | 2011 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.7B |
| IPO Year | 2017 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CELC | IAC |
|---|---|---|
| Price | $115.02 | $37.81 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 13 |
| Target Price | ★ $106.63 | $45.75 |
| AVG Volume (30 Days) | 538.8K | ★ 993.0K |
| Earning Date | 01-01-0001 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 79.97 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $4,365,235,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $0.48 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.58 | $29.56 |
| 52 Week High | $120.32 | $50.49 |
Technical Indicators
Market Signals| Indicator | CELC | IAC |
|---|---|---|
| Relative Strength Index (RSI) | 56.96 | 53.85 |
| Support Level | $97.75 | $34.56 |
| Resistance Level | $114.54 | $38.28 |
| Average True Range (ATR) | 5.27 | 1.10 |
| MACD | 0.32 | 0.07 |
| Stochastic Oscillator | 67.83 | 69.16 |
Price Performance
Historical ComparisonAbout CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About IAC IAC Inc.
IAC Inc is comprised of businesses including Angi Inc, Dotdash Meredith and Care.com, among many others ranging from early stage to established businesses. Its Dotdash Meredith segment consists of its Digital and Print businesses. Angi segment offers repairing and remodeling homes to cleaning and landscaping services. Care.com segment is a online destination for families to connect with caregivers for their children, aging parents, pets and homes and for caregivers to connect with families seeking care services. Search segment consists of a collection of websites providing general search services and information, and a Desktop business, which includes business-to-business partnership operations.